This site is part of the Siconnects Division of Sciinov Group

This site is operated by a business or businesses owned by Sciinov Group and all copyright resides with them.

ADD THESE DATES TO YOUR E-DIARY OR GOOGLE CALENDAR

Registration
Event
Hybrid Event

Accelerate Ideas, Partnerships and Opportunities

Book your SLOT NOW
  • Start 9:00am - 6:00pm
  • Rome, Italy
 

About Conference

Sciinov Group is proud to announce the Oligonucleotide Therapeutics and Delivery Conference, 23-24 March, 2026 in Rome, Italy. This year OTDC 2026 annual Oligonucleotide Therapeutics and Delivery conference will showcase recent advances in oligonucleotide development, regulatory requirements and CMC considerations, strategies to enhance oligonucleotide discovery and targeting and optimised delivery techniques for oligonucleotide-based therapies, in the hope to continue to drive forward the field of oligonucleotide drug development. Join us on the 23 March, 2026 at Rome, Italy.


Industry and academic experts deliver detailed case studies on antisense, RNA, GalNAc, aptamers, conju...

Readmore

Author's Login
Abstract Tracking Tool

ask & questions

answer

We are always looking for new industry leaders to join our speaker faculty to deliver presentations, lead panel discussions and moderate sessions or roundtables. 
If you are interested in being considered as a speaker, submit your proposal/abstract Online

answer

We let speakers propose the topic they want to talk about. This process allows speakers to propose sessions that speak from their expertise and passion.
Speaker can choose the topic of your choice in related to the conference subject or any of their recent research work to present at our conference.
For details of scientific sessions covered please visit [not limited to, you can propose]  

 

answer

Please visit the page here

answer

Yes, as our conference is scheduled in Hybrid Mode, you can present and listen to full program virtually connecting via ZOOM live stream


Recent Updates

04 Apr
2025

A cellular regulator of mRNA vaccines has been discovered, opening up new therapeutic possibilities

Dr. Kim V. Narry's team at the Institute for Basic Science has revealed a key cellular mechanism affecting mRNA vaccine function, offering insights to improve RNA-based treatments.Readmore

09 Apr
2025

Engineering Efficient Delivery Methods for Gene Editing

A team from Helmholtz Munich and the Technical University of Munich has developed ENVLPE, an advanced delivery system that uses engineered virus-like particles to efficiently transport CRISPR/Cas9 gene-editing tools into cells.Readmore

09 Apr
2025

Ractigen's RAG-17 ALS Data Impresses at AAN 2025: Wins Top Award, Phase I Progresses

Ractigen Therapeutics announced that the final positive results from the Investigator-Initiated Trial (IIT) of RAG-17, a siRNA therapy for ALS targeting SOD1, were presented for the first time at the AAN 2025 Annual Meeting in San Diego. Readmore

09 Apr
2025

New Gene Editing Tool Shows Promise for Treating Diseases with Multiple Mutations

Scientists at Mass General Brigham and Beth Israel have developed STITCHR, an RNA-only gene editing tool that inserts full genes precisely without unwanted mutations. Readmore


08:00

Day 1: Innovations in Oligonucleotide Therapeutics

08:00 - 09:00

"Registration & Networking Breakfast Meet fellow attendees and start the day with informal networking."

09:00 - 09:15

"Keynote Session: The Future of Oligonucleotide Therapeutics Exploring advancements in RNA-based therapies, ASOs, and siRNA treatments."

09:15 - 10:00

"Keynote Session: The Future of Oligonucleotide Therapeutics Exploring advancements in RNA-based therapies, ASOs, and siRNA treatments."

10:00 - 10:45

"Session 1: Breakthroughs in RNAi and Antisense Oligonucleotides a. Advances in antisense oligonucleotides (ASOs) and siRNA b. Case studies on novel RNA-based therapeutics"

10:45 - 11:15

Coffee Break & Networking

11:15 - 12:15

"Panel Discussion: Overcoming Challenges in Oligonucleotide Drug Development a. Regulatory hurdles and approval pathways b. Manufacturing scalability and cost challenges c. Stability and delivery issues"

12:15 - 13:15

Lunch Break & Networking

13:15 - 14:00

"Industry Insights: Manufacturing & Scale-Up of Oligonucleotide Therapies a. GMP manufacturing and quality control challenges b. Trends in large-scale production"

14:00 - 14:45

"Session 3: AI & Computational Approaches in Oligonucleotide Drug Design a. Role of AI in target selection and design optimization b. Predictive modeling for therapeutic efficacy"

14:45 - 15:15

Afternoon Coffee Break

15:15 - 16:00

"Industry Case Study: Recent Successes in Oligonucleotide Therapies a. A biotech/pharma company shares insights on successful drug development."

16:00 - 17:00

"Roundtable Discussions & Interactive Q&A Breakout sessions focusing on specific therapeutic areas and delivery challenges."

17:00 - 18:00

"Networking Cocktail Reception A relaxed setting to connect with industry experts and researchers."

08:30

Day 2: Advances in Oligonucleotide Delivery & Clinical Applications

08:30 - 09:00

Morning Coffee & Networking

09:00 - 09:45

"Keynote Session: Next-Generation Delivery Systems for Oligonucleotides Exploring lipid nanoparticles, exosomes, and polymer-based carriers."

09:45 - 10:30

"Session 4: Overcoming Barriers in Extrahepatic Delivery a. Advances in tissue-specific delivery b. Strategies for targeting CNS, muscle, and lung tissues"

10:30 - 11:00

Networking Coffee Break

11:00 - 12:00

"Panel Discussion: Regulatory & Commercialization Strategies a. FDA/EMA regulatory pathways b. Pricing and market access challenges"

12:00 - 13:00

Lunch Break & Poster Sessions

13:00 - 13:45

"Session 5: Oligonucleotide Conjugation and Chemical Modifications a. Enhancing stability and specificity through novel chemical modifications b. Conjugation strategies for improved therapeutic outcomes"

13:45 - 14:30

"Industry Insights: Manufacturing & Scale-Up of Oligonucleotide Therapies a. GMP manufacturing and quality control challenges b. Trends in large-scale production"

14:30 - 15:00

Afternoon Coffee Break

15:00 - 15:45

"Emerging Technologies Showcase: Startups & Innovation Pitches a. New technologies in oligonucleotide discovery and delivery b. Emerging biotech startups present their innovations"

15:45 - 16:30

"Fireside Chat: The Future of Oligonucleotide-Based Precision Medicine a. Personalized medicine applications b. Future directions in gene-targeted therapies"

16:30 - 17:00

"Closing Remarks & Key Takeaways Summary of insights and discussions from the two-day event."

17:00

Thanks giving & Conference Closure

Get more information

make a booking now

Market Reports

Subscribe to our News & Updates